HomeCompareSPNE vs EQR

SPNE vs EQR: Dividend Comparison 2026

SPNE yields 20.96% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SPNE wins by $29.7K in total portfolio value
10 years
SPNE
SPNE
● Live price
20.96%
Share price
$9.54
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.5K
Annual income
$7,459.80
Full SPNE calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — SPNE vs EQR

📍 SPNE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSPNEEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SPNE + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SPNE pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPNE
Annual income on $10K today (after 15% tax)
$1,781.97/yr
After 10yr DRIP, annual income (after tax)
$6,340.83/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, SPNE beats the other by $1,686.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPNE + EQR for your $10,000?

SPNE: 50%EQR: 50%
100% EQR50/50100% SPNE
Portfolio after 10yr
$62.6K
Annual income
$6,467.70/yr
Blended yield
10.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

SPNE
Analyst Ratings
9
Buy
1
Hold
Consensus: Buy
Price Target
$9.38
-1.7% upside vs current
Range: $6.75 — $12.00
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPNE buys
0
EQR buys
0
No recent congressional trades found for SPNE or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSPNEEQR
Forward yield20.96%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$77.5K$47.8K
Annual income after 10y$7,459.80$5,475.61
Total dividends collected$45.1K$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold
Analyst price target$9.38$70.35

Year-by-year: SPNE vs EQR ($10,000, DRIP)

YearSPNE PortfolioSPNE Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$12,796$2,096.44$11,380$679.82+$1.4KSPNE
2$16,199$2,507.19$13,014$837.25+$3.2KSPNE
3$20,300$2,966.28$14,961$1,036.20+$5.3KSPNE
4$25,194$3,473.91$17,297$1,289.22+$7.9KSPNE
5$30,988$4,029.51$20,121$1,613.15+$10.9KSPNE
6$37,789$4,631.81$23,561$2,030.84+$14.2KSPNE
7$45,713$5,278.85$27,783$2,573.54+$17.9KSPNE
8$54,881$5,968.03$33,013$3,284.39+$21.9KSPNE
9$65,418$6,696.22$39,547$4,223.51+$25.9KSPNE
10$77,457$7,459.80$47,791$5,475.61+$29.7KSPNE

SPNE vs EQR: Complete Analysis 2026

SPNEStock

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.

Full SPNE Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this SPNE vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPNE vs SCHDSPNE vs JEPISPNE vs OSPNE vs KOSPNE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.